SARS-CoV-2 Rapid Antigen Test Nasal Pack of 25

Rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 present in human nasal specimens.
In clinical studies, the SARS-CoV-2 Rapid Antigen Test Nasal showed a relative sensitivity of 90.6% (Ct value ≤ 30; 95 % CI: 75.0 % – 98.0 %) and a specificity of 98.6% for professionally collected samples.
For self-collected samples, a sensitivity of 84.4 % (Ct value ≤ 30; 95 % CI: 67.2 % – 94.7 %) and a specificity of 99.2% was detected.
Overall, the studies contained 468 symptomatic and asymptomatic individuals.
This test is intended to detect antigen from SARS‑CoV‑2 in individuals suspected of COVID‑19 or with known or suspected exposure to SARS‑CoV‑2.
Intended for Professional use in Laboratory and Point of Care Environments, and/or self-collection under the close supervision of a healthcare worker.
Kit Contents:

• Test Device (individually in a foil pouch with desiccant)
• Extraction buffer tube and buffer tube rack
• Nozzle cap
• Sterile swab
• Quick Reference Guide
• Instructions for use
• Positive and negative controls
• Pack of 25 - includes quantity of 1 Extraction buffer tube and so to be used in a group situation

Limitations of COVID-19 antigen testing
No test is 100% accurate. All tests have limitations.
The antigen test is less accurate than the COVID-19 PCR test.
The test will find the virus in most people who have symptoms.
But in some cases, it may not pick up that you have the virus.
If you have COVID-19 symptoms, tell a healthcare worker immediately.